Nov, 2019 Pharma & Healthcare
Global Liver Fibrosis Drug Market Status 2019 - Projections Report 2026
Category by- Pharma & Healthcare , No. of Pages - 105, Published By - QYR
The global Liver Fibrosis Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Liver Fibrosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liver Fibrosis Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Bird Rock Bio, Inc.
Bristol-Myers Squibb Company
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Gilead Sciences, Inc.
GNI Group Ltd.
HEC Pharm Co., Ltd.
Dr. Falk Pharma GmbH
LG Life Science LTD.
Nitto Denko Corporation
Dynavax Technologies Corporation
Segment by Regions
Segment by Type
Segment by Application